av/takeda--big.svg

NYSE:TAK

Takeda Pharmaceutical Company Limited

  • Stock

4,419.00

+1.08%

47.00

USD last updated 22/08 01:42:20

Last Close

4,372.00

02/05 06:30

Market Cap

6.77T

Beta: 0.68

Volume Today

3.88M

Avg: 2.34M

PE Ratio

18.10

PFCF: −50.39

Dividend Yield

0.01%

Payout:161.87%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
Mar '25
revenue
1.78T
-
1.81T
1.66%
1.73T
4.17%
1.77T
2.22%
2.10T
18.45%
2.10T
0%
3.20T
52.48%
3.57T
11.61%
3.57T
0%
4.26T
19.47%
4.58T
7.45%
cost of revenue
520.99B
-
535.40B
2.77%
558.75B
4.36%
495.92B
11.25%
659.69B
33.02%
659.69B
0%
994.31B
50.72%
1.11T
11.32%
1.11T
0%
2.08T
87.81%
2.22T
6.96%
gross profit
1.26T
-
1.27T
1.20%
1.17T
7.76%
1.27T
8.63%
1.44T
12.78%
1.44T
0%
2.20T
53.28%
2.46T
11.74%
2.46T
0%
2.18T
11.26%
2.36T
7.92%
selling and marketing expenses
general and administrative expenses
selling general and administrative expenses
612.61B
-
650.77B
6.23%
619.06B
4.87%
628.11B
1.46%
717.60B
14.25%
717.60B
0%
875.66B
22.03%
886.36B
1.22%
886.36B
0%
1.05T
18.89%
1.10T
4.83%
research and development expenses
382.10B
-
345.93B
9.47%
312.30B
9.72%
325.44B
4.21%
368.30B
13.17%
368.30B
0%
455.83B
23.77%
526.09B
15.41%
526.09B
0%
729.92B
38.75%
730.23B
0.04%
other expenses
1.00T
-
795.22B
20.79%
705.13B
11.33%
707.38B
0.32%
908.87B
28.48%
908.87B
0%
1.41T
55.07%
588.87B
58.22%
588.87B
0%
-11.05B
101.88%
cost and expenses
1.91T
-
1.68T
12.09%
1.58T
5.99%
1.53T
3.01%
1.94T
26.70%
1.94T
0%
2.69T
38.81%
3.11T
15.61%
3.11T
0%
3.86T
24.27%
4.06T
5.07%
operating expenses
1.39T
-
1.14T
17.67%
1.02T
10.84%
1.03T
1.51%
1.28T
23.66%
1.28T
0%
1.69T
32.66%
2.00T
18.12%
2.00T
0%
1.78T
10.87%
1.83T
2.87%
interest expense
32.88B
-
31.93B
2.88%
23.25B
27.19%
31.93B
37.32%
48.16B
50.83%
48.16B
0%
248.63B
416.28%
166.61B
32.99%
166.61B
0%
119.53B
28.25%
210.06B
75.74%
ebitda
148.39B
-
349.85B
135.76%
389.38B
11.30%
431.26B
10.75%
376.38B
12.72%
376.38B
0%
1.17T
212.06%
1.05T
10.40%
1.05T
0%
1.13T
7.31%
1.15T
1.89%
operating income
-129.25B
-
130.83B
201.22%
155.87B
19.14%
241.79B
55.13%
204.97B
15.23%
204.97B
0%
509.27B
148.46%
460.84B
9.51%
460.84B
0%
401.22B
12.94%
523.11B
30.38%
depreciation and amortization
260.95B
-
197.38B
24.36%
222.79B
12.87%
182.13B
18.25%
272.45B
49.59%
272.45B
0%
559.67B
105.42%
583.15B
4.20%
591.49B
1.43%
167.90K
100.00%
761.40B
453,495,239.35%
total other income expenses net
1.34B
-
-3M
100.22%
-1.55B
51,433.33%
-32.20B
1,982.73%
-4.51B
85.99%
-4.51B
0%
76M
101.69%
-15.37B
20,319.74%
-158.27B
929.95%
-354.91B
124.24%
-344.04B
3.06%
income before tax
-145.44B
-
120.54B
182.88%
143.35B
18.92%
217.21B
51.52%
94.90B
56.31%
94.90B
0%
366.24B
285.93%
302.57B
17.38%
302.57B
0%
46.32B
84.69%
179.07B
286.61%
income tax expense
-2.40B
-
37.06B
1,642.20%
27.83B
24.90%
30.50B
9.57%
-14.12B
146.29%
-14.12B
0%
-9.94B
29.62%
72.41B
828.71%
72.41B
0%
-91.41B
226.24%
66.94B
173.23%
net income
-145.78B
-
80.17B
154.99%
114.94B
43.38%
186.89B
62.59%
109.13B
41.61%
109.13B
0%
376.00B
244.56%
230.06B
38.81%
230.06B
0%
144.07B
37.38%
107.93B
25.08%
weighted average shs out
786.40M
-
783.94M
0.31%
781.10M
0.36%
780.81M
0.04%
961.48M
23.14%
961.48M
0%
1.56B
62.46%
1.56B
0.10%
1.56B
0%
1.56B
0.06%
1.58B
0.92%
weighted average shs out dil
786.40M
-
788.18M
0.23%
785.89M
0.29%
786.71M
0.10%
966.90M
22.90%
966.90M
0%
1.57B
62.74%
1.58B
0.23%
1.58B
0%
1.58B
0.20%
1.61B
1.58%
eps
-185.37
-
102.26
155.17%
147.15
43.90%
239.35
62.66%
113.50
52.58%
113.50
0%
240.72
112.09%
147.14
38.88%
147.14
0%
92.09
37.41%
68.36
25.77%
epsdiluted
-185.37
-
101.71
154.87%
146.26
43.80%
237.55
62.42%
112.86
52.49%
112.86
0%
238.96
111.73%
145.87
38.96%
145.87
0%
91.16
37.51%
67.23
26.25%

All numbers in USD (except ratios and percentages)